Clinical Trials Browser

Phase 2 × Lung Neoplasms × Fibroblast Growth Factor 7 × Clear all

NCT00094861 2017-03-14

Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

100 enrolled 19 charts

Carcinoma, Non-Small-Cell Lung, Deglutition Disorders, Lung Neoplasms